COPE Intervention for Women with Breast Cancer During First-Line Therapy

This study is testing an intervention called "Creating Opportunities for Personal Empowerment" (COPE) for women with breast cancer who are starting their first treatment. The COPE intervention involves 7 weekly sessions led by a nurse, designed to help you cope with your diagnosis. Researchers want to see if this intervention is practical to deliver, if women find it helpful, and how it compares to standard care. They will measure how you feel and cope over about one year. You may be able to join if you are a woman aged 18 or older, have stage I-III breast cancer, are receiving your first treatment at MD Anderson, and can read and speak English. This study is currently recruiting 40 participants.

Study design
This is an interventional, randomized controlled trial with 40 participants. It compares the COPE intervention to standard care.
What's involved
You would complete questionnaires and participate in 7 weekly intervention sessions. This would last for about one year.
Compensation
Not stated in the trial record.
Follow-up
You will be followed through study completion, which is an average of one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07610499

Creating Opportunities For Personal Empowerment (COPE) In Women With Breast Cancer During First-Line Therapy: A Pilot Randomized Controlled Trial

Not Yet Recruiting
NAAges 18+InterventionalSupportive care
M.D. Anderson Cancer Center
~40 participants
Updated 2026-05-28 on ClinicalTrials.gov
What's tested:Standard of Care (SOC)Intervention sessions

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient-Reported Outcomes Measurement Questionnaire
Measured over Through study completion; an average of 1 year
COPE
Breast Cancer
First Line Therapy
Randomized Controlled Trial (RCT)
1 sites across 1 states
Texas1
  • Eileen D Hacker, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

Diagnosed with multiple tumor types
Diagnosed with stage IV breast cancer
Unable to provide consent, such as cognitively impaired individuals
Has a preexisting psychiatric diagnosis (e.g., bipolar depression)
  • Patient-Reported Outcomes Measurement QuestionnaireThrough study completion; an average of 1 year